Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

The latest news and analysis of the pharmaceutical and biotech business landscape. Including staff moves, product launches, acquisitions, mergers, collaborations and licensing agreements.

Showing 15 posts of 2378 posts found.

Croda International acquires Solus Biotech

July 4, 2023 Business Services Croda International, Pharmacy, Solus Biotech, acquisition

Croda International has confirmed that it has successfully acquired Solus Biotech, following receipt of approval from the South Korean regulatory …
News

Josef Penninger appointed as new scientific director of Helmholtz Centre for Infection Research

July 3, 2023 Business Services Helmholtz Centre for Infection Research, Josef Penninger, appointment, scientific director

The Helmholtz Centre for Infection Research (HZI), Germany, has appointed Professor Josef Penninger as scientific director. Penninger has previously worked …
Appointment

Kevin Hawkins appointed as Reacta’s head of regulatory affairs

July 3, 2023 Business Services Kevin Hawkins, Reacta, appointment, head of regulatory affairs

Reacta Healthcare, an early-stage food allergy diagnostic company, has announced the appointment of Kevin Hawkins as head of regulatory affairs. …
Appointment
hal-gatewood-_jbclosdsd4-unsplash

Eli Lilly to acquire Sigilon Therapeutics

June 30, 2023 Business Services Chronic Diseases, Eli Lilly, Sigilon, acquisition

Eli Lilly and Sigilon Therapeutics have announced a definitive agreement for Lilly’s acquisition of Sigilon, a biopharmaceutical company focusing on …
News
money_pills_2

Zymeworks to open new EU HQ in Dublin, Ireland

June 22, 2023 Business Services Dublin, Oncology, Zymeworks, headquarters, regulatory affiars

Canadian biotech company Zymeworks has announced plans to open its new Clinical and Regulatory EU headquarters in Dublin, Ireland. Zymework …
News

Eli Lilly to acquire DICE Therapeutics for immunology innovations

June 21, 2023 Business Services DICE Therapeutics, Eli Lilly, Immunology, acquisition, immunology

Eli Lilly and DICE Therapeutics have announced a definitive agreement for Lilly to acquire DICE, a biopharmaceutical company focusing on …
News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

AstraZeneca’s breast cancer drug given Priority Review by FDA

June 13, 2023 Business Services AstraZeneca, FDA, Oncology, breast cancer

UK-based pharmaceutical company AstraZeneca has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application …
News

Inizio launches strategic engagement offering to transform customer experiences

June 7, 2023 Business Services Inizio, Inizio Engage, commercialisation

6 June 2023 – London, UK — Inizio, a global commercialisation partner dedicated to the health and life sciences industry, …
News
Press release

FlyPharma Europe, Vienna: the early bird deal for FlyPharma Vienna closes on 24 May

May 9, 2023 Business Services, Conferences Conference, flypharma

Act now! The early bird deal for FlyPharma Vienna closes on 24 May. Contact Angela Heath, conference director, email angela@samedanltd.com for …
News
Press release

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa

April 27, 2023 Business Services CHMP, Cosentyx, Dermatology, Novartis

Basel, April 26, 2023 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …
News
Press release

Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology

April 26, 2023 Business Services

Boston, Massachusetts, April 26, 2023 – Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, …
News
Press release

Epsilogen announces significant expansion of management team with three new senior hires

April 26, 2023 Business Services

London, 26 April 2023 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to …
News
Press release

Real-world data analysis shows significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr® app in UK users with type 2 diabetes

April 26, 2023 Business Services

Burgess Hill, 26 April 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that real world data shows a …
News
Press release

MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases

April 25, 2023 Business Services

London, United Kingdom, April 25, 2023 — MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a multi-target …
News
Press release

PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

April 25, 2023 Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …
News
Press release

Latest content

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024

Vertex shares results from phase 1/2 trial of type 1 diabetes treatment

June 24, 2024

Gilead shares phase 3 results from HIV prevention trial

June 21, 2024

Sarepta Therapeutics gains expanded FDA approval for DMD treatment

June 21, 2024

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024